| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.001 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |